Drugmaker Astra Zeneca announced on Monday that its experimental coronavirus vaccine has shown an average efficacy of 70 % in its large scale trials -- the latest of several vaccine trials worldwide to post their results this month . 
The vaccine , developed with the University of Oxford , showed 90 % efficacy in one dosing regimen , and 62 % efficacy in a second regimen . 
That averages to a 70 % efficacy , Astra Zeneca said . 
The interim analysis included a total of 131 Covid 19 cases , according to the release . 
Other vaccines in the works : This comes after Moderna announced earlier this month that its vaccine was 94.5 % effective against coronavirus , and Pfizer announced its vaccine was 95 % effective . 
